New hope for managing dizzy spells in rare neurological disease
Symptom relief
Ongoing
This study is testing whether a drug called ampreloxetine can safely and effectively reduce symptoms of low blood pressure when standing in people with multiple system atrophy (MSA). About 102 participants will take the drug for 20 weeks, then some will be randomly switched to a …
Phase: PHASE3 • Sponsor: Theravance Biopharma • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC